Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 37 clinical trials
Exercise and NO in HFrEF

productivity. Heart failure with a reduced ejection fraction (HFrEF), a clinical syndrome that develops as a consequence of heart disease, now affects almost 6 million Americans. Within the VA Health Care

  • 11 Jul, 2021
  • 1 location
A Pilot Study of High Intensity Walking in Older Adults in the Pre-operative Period

The purpose of this pilot study is to evaluate a high intensity walking intervention in older surgical candidates with kidney or thoracic disease and pre-frailty or frailty.

  • 25 Jan, 2021
  • 1 location
Clinical Study of Umbilical Cord Mesenchymal Stem Cells Infusion for Aging Frailty

The purpose of this clinical study is to answer the questions: Is the proposed intervention safe? Is the proposed intervention effective in improving the healthy status of subjects with aging frailty?

  • 14 Mar, 2021
  • 1 location
Limitations of Aerobic Capacity in Chronic Heart Failure

This study will use a novel CPX test that incorporates instantaneous assessment of maximal isokinetic cycling power at VO2peak to elucidate the mechanisms that limit VO2peak in CHF, and compare these responses with age-matched controls.

  • 08 May, 2021
  • 1 location
Implementation of the Individual Danish Emergency Process Triage

The purpose of the study is to implement and evaluate a novel triage algorithm for risk stratification of acutely admitted patients in the Emergency Department.

  • 25 Jan, 2021
  • 8 locations
Ginkgo Leaf Extract and Armillariella Mellea Powder Oral Solution for the Treatment of Motoric Cognitive Risk Syndrome

This is a multi-centre, randomised, double blind, placebo controlled study on participants with Motoric Cognitive Risk Syndrome to evaluate the efficacy and safety of Ginkgo Leaf Extract and Armillariella Mellea Powder Oral Solution.

ginkgo biloba
  • 16 Dec, 2021
  • 1 location
Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)

The purpose of the study is to examine how Kallmann syndrome (KS) and idiopathic hypogonadotropic hypogonadism (IHH) affect reproductive hormones. These disorders are caused by a defect in Gonadotropin Releasing Hormone (GnRH) secretion. GnRH is a hormone released by a small gland in the brain called the hypothalamus. When GnRH …

testosterone level
kallmann syndrome
serum testosterone
klinefelter syndrome
idiopathic hypogonadotropic hypogonadism
  • 22 Aug, 2021
  • 1 location
Boxing Training for Upper Limb Functions, Balance, and Quality of Life in Stroke

The World Health Organization's (WHO) definition of stroke is a clinical syndrome characterized by rapidly developing clinical signs of focal (or global) disturbance of cerebral function lasting

  • 05 Jan, 2022
  • 1 location
SEPSIS: L. Plantarum Trial

Sepsis is a life-threatening clinical syndrome and a leading cause of neonatal deaths worldwide. The burden of neonatal sepsis and severe infection (SI) is particularly high in areas of South

Accepts healthy volunteers
  • 17 Jan, 2022
  • 2 locations
RescuE pLAsma eXchange in Severe COVID-19

cytokine storm-like clinical syndrome with high mortality. Laboratory tests in these patients show an excessive and uncontrolled immune response with consecutive multi-organ failure. In addition, there is

  • 02 Jan, 2022
  • 4 locations